Cargando…

Validation of Hepascore as a Predictor of Liver Fibrosis in Patients with Chronic Hepatitis C Infection

Introduction. Liver biopsy is an invasive determinator for hepatic fibrosis. Serum biomarkers can probably be used as an alternative to liver biopsy in assessment of the degree of fibrosis in patients with chronic Hepatitis C. Method. Eighty patients with chronic Hepatitis C were included in the stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalantari, Hamid, Hoseini, Hannan, Babak, Anahita, Yaran, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255101/ https://www.ncbi.nlm.nih.gov/pubmed/22254137 http://dx.doi.org/10.1155/2011/972759

Ejemplares similares

Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
por: Jeffrey, Angus W, et al.
Publicado: (2017)

Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis
por: Ong, Sim Yee, et al.
Publicado: (2021)

Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Bertot, Luis C., et al.
Publicado: (2023)

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
por: Ataei, Behrooz, et al.
Publicado: (2011)

Correlation between Vitamin D3 level and extrahepatic manifestation in chronic hepatitis type-C virus patients
por: Kalantari, Hamid, et al.
Publicado: (2018)

Efficacy of Double Dose Recombinant Hepatitis B Vaccination in Chronic Hepatitis C Patients, Compared to Standard Dose Vaccination
por: Minakari, Mohammad, et al.
Publicado: (2014)

Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran
por: Kalantari, Hamid, et al.
Publicado: (2016)

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
por: Calès, Paul, et al.
Publicado: (2008)

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
por: Kassaian, Nazila, et al.
Publicado: (2011)

Hepascore predicts liver outcomes and all‐cause mortality in long‐term methotrexate users: A retrospective cohort study
por: Wang, Zhengyi, et al.
Publicado: (2020)

Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran
por: Kalantari, Hamid, et al.
Publicado: (2014)

Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection
por: Reese, Lindsey J., et al.
Publicado: (2012)

A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection
por: Cheng, Danying, et al.
Publicado: (2020)

The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer
por: Kondo, Takayuki, et al.
Publicado: (2016)

Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma
por: Wang, Q, et al.
Publicado: (2013)

Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging
por: Pan, Shen, et al.
Publicado: (2018)

Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
por: Batista, Andrea Dória, et al.
Publicado: (2018)

The Role of Liver Fibrosis Assessment in the Management of Patients with Chronic Hepatitis B Infection: Lessons Learned from a Single Centre Experience
por: Malik, Raza, et al.
Publicado: (2011)

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
por: Soto, Marcelo, et al.
Publicado: (2017)

Predictors of survival after hepatic resection among patients with colorectal liver metastasis
por: Wang, X, et al.
Publicado: (2007)

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C
por: Kuo, Ming-Te, et al.
Publicado: (2014)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection
por: Poovorawan, Kittiyod, et al.
Publicado: (2013)

Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
por: Paranaguá-Vezozzo, Denise C, et al.
Publicado: (2017)

Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

Parameters Associated with Significant Liver Histological Changes in Patients with Chronic Hepatitis B
por: Xiao, Li, et al.
Publicado: (2014)

Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients
por: Abe, Hiroshi, et al.
Publicado: (2014)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Diagnostic Value of Pyruvate Kinase Isoenzyme Type M2 in Colon Cancer Proven with Colonoscopy
por: Kalantari, Hamid, et al.
Publicado: (2020)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
por: Hanna, Robert F., et al.
Publicado: (2014)

The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran
por: Kalantari, Hamid, et al.
Publicado: (2012)

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
por: Wani, Hamid Ullah, et al.
Publicado: (2014)

Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients
por: Gabr, Sami A., et al.
Publicado: (2021)

Associations between Vitamin D and Liver Function and Liver Fibrosis in Patients with Biliary Atresia
por: Zhuang, Peijun, et al.
Publicado: (2019)

APRI Score as a Predictor of Significant Liver Fibrosis in Chronic Hepatitis B
por: Ayed, Houda Ben, et al.
Publicado: (2017)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
por: Martinez-Castillo, Moises, et al.
Publicado: (2021)

Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
por: Yao, Qun-Yan, et al.
Publicado: (2020)

Is herbal medicine effective in the management of patients with chronic hepatitis C?
por: Kalantari, Hamid, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5kv50gjn79t3nfs1i05j31naj1